Business
Crescita to Present at the 9th Annual LD Micro Invitational in Los Angeles, California
Crescita to Present at the 9th Annual LD Micro Invitational in Los Angeles, California ...
About this update from Crescita Therapeutics, Inc.
[{"type":"text","content":"\n\n\n\nCrescita to Present at the 9th Annual LD Micro Invitational in Los Angeles, California\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\n\nCanada NewsWire\nLAVAL, QC, May 30, 2019\n\n\n\nLAVAL, QC, May 30, 2019 /CNW/ - Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) (Crescita or the Company), a Canadian commercial dermatology company with a portfolio of non-prescription skincare products and prescription drug products for the treatment and care of skin conditions, diseases and their symptoms, announced today that its Executive Chairman, Dan Chicoine will be presenting at the 9th annual LD Micro Invitational on Tuesday, June 4th at 3:00 p.m. pacific time. Mr. Chicoine accompanied by Ms. Linda Kisa, Crescita's director of investor relations, will also be meeting with investors one-on-one. \n\n \n \n\n \n\"We are very excited to be presenting at this prestigious conference and we look forward to introducing Crescita to a new list of potential U.S. investors\" stated Dan Chicoine, executive chairman. \nThe LD Micro Invitational will take place June 4th and 5th in Los Angeles, at the Luxe Sunset Bel Air Hotel, will feature 230 companies, and will be attended by over 1,000 individuals.\nPlease visit https://www.ldmicro.com/profile/CTX.TO to view Crescita Therapeutics' profile.\nAbout Crescita Therapeutics Inc.Crescita (TSX: CTX and OTC US: CRRTF) is a publicly traded, Canadian commercial dermatology company with a portfolio of non-prescription skincare products and prescription drug products for the treatment and care of skin conditions and diseases and their symptoms. Crescita owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active drugs into or through the skin. Please visit www.crescitatherapeutics.com for additional information.\nAbout LD MicroLD Micro was founded in 2006 with the sole purpose of being an independent resource in the microcap space. What started out as a newsletter highlighting unique companies has transformed into s...